The Indian government proposes to amend drug import regulations, expanding entry points to enhance supply chain efficiency and reduce logistics costs for medical products. New Delhi: The Centre has proposed an amendment to Rule 43A of the Drugs Rules, 1945, to expand the network of authorised entry points for the import of drugs, medical devices into the country.